Chan Tan
Neurology · Toledo, OHNPI 1518131853
Payments from drug & device makers
Across 138 payments — averaging $97.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$4K
- Imperative Care, Inc$3K
- Stryker$2K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$820
- Medtronic$515
- plus $1K from 19 others
What the payments were for
- Travel & lodging$7,14653%
- Food & beverage$6,36447%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 15 | $4,173 |
| Imperative Care, Inc | 27 | $2,724 |
| Stryker | 14 | $2,225 |
| Medical Device Business Services, Inc. | 16 | $1,657 |
| Johnson & Johnson(2 entities) | 30 | $820 |
| Medtronic | 10 | $515 |
| Microvention, Inc. | 1 | $206 |
| Route 92 Medical, Inc. | 3 | $177 |
| Scientia Vascular | 1 | $170 |
| Argenx US, Inc. | 2 | $128 |
| Janssen Scientific Affairs, LLC | 1 | $122 |
| AstraZeneca(2 entities) | 3 | $121 |
| Eisai Inc. | 1 | $120 |
| Siemens Medical Solutions USA, Inc. | 1 | $90 |
| UCB, Inc. | 1 | $74 |
| Cardiva Medical, Inc. | 2 | $46 |
| Azurity Pharmaceuticals, Inc. | 2 | $28 |
| Bayer | 1 | $21 |
| Novartis | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| Nevro Corp. | 1 | $16 |
| Lilly USA, LLC | 1 | $13 |
| Pfizer | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $8 |
| Asahi Intecc USA, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$3,708
- ZOOM 88-T LARGE DISTAL PLATFORM$2,114
- EVOLVE$1,697
- CEREPAK UNIFORM$1,296
- Embotrap$1,296
- TRUFILL$1,190
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$1,190
- OSTEOCOOL RF ABLATION SYSTEM$175
- 8F Base Camp Sheath System$138
- XARELTO$122
- AXS VECTA 71$121
- Leqembi$120
- TARGET$117
- Pipeline$117
- POD$108
- EMBOGUARD$106
- Penumbra Coil 400$101
How this compares
$13,514 in reported general payments places this provider in the 70th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $13,039 |
| ClopidogrelClopidogrel Bisulfate | 114 | $997 |
| Carbamazepine ErCarbamazepine | 11 | $894 |
| Atorvastatin Calcium | 27 | $281 |
| Levetiracetam | 11 | $187 |
| Rosuvastatin Calcium | 36 | $151 |
| Topiramate | 30 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $13 | $13,03916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 702 neurology providers in Ohio.
Other neurology in Toledo
- Lawrence ElmerToledo$1.5M
- Mouhammad JumaaToledo$1.1M
- Howard SchechtToledo$564K
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
- Robert BermelCleveland$6.4M
- Aaron BosterColumbus$6.3M
- Ryan DrakeCanton$5.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.